New Pill Approved for Schizophrenia, Bipolar Disorder

By News Health
4 weeks Ago

(MedPage Today) — The FDA approved milsaperidone (Bysanti) tablets as first-line therapy for adults with schizophrenia and manic or mixed episodes related to bipolar I disorder, Vanda Pharmaceuticals announced on Friday.
Milsaperidone is an active…

Source link : https://www.medpagetoday.com/psychiatry/bipolardisorder/120004

Author :

Publish date : 2026-02-23 20:49:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

I spent five months in a mother and baby mental health unit - here's what I want mums to know

Quiz Time: Whose Son Won't Get Antibiotics Unless on 'His Deathbed'?

Glaucoma Checks in Primary Care; Wastewater to Screen for Colorectal Cancer

To Limit Antibiotic Overprescribing, Take a Page From the Opioid Epidemic

Gene Therapy Supply Runs Out, Company Warns of Treatment Delays

RFK Jr. Touts Food as Medicine. He Often Overstates the Science, Experts Say.